Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation (NASDAQ: DNEX) through a short-form merger.
Pursuant to the terms of the merger, all outstanding Dionex shares (other than those held by Thermo Fisher, Dionex or any wholly owned subsidiary of Dionex, and any shareholders who validly exercised their appraisal rights in connection with the merger) will be exchanged for $118.50 per share in cash.
Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development